Rationale: Kv1.5 (KCNA5) mediates the ultra-rapid delayed rectifier current that controls atrial action potential duration. Given its atrial-specific expression and alterations in human atrial fibrillation, Kv1.5 has emerged as a promising target for the treatment of atrial fibrillation. A necessary step in the development of novel agents that selectively modulate trafficking pathways is the identification of the cellular machinery controlling Kv1.5 surface density, of which little is yet known. 
A trial fibrillation (AF) is the most common cardiac arrhythmia and represents a significant health risk to the population. Therapy for AF seeks to restore normal sinus rhythm through pharmacological cardioversion. [1] [2] [3] [4] Lack of ion channel selectivity and overlap in ion channel expression in the atria and ventricles, however, underlies the nonspecific ventricular side effects of current pharmacological agents. 5, 6 Therefore, strategies for the treatment of AF, targeting ion channels selectively expressed in the human atria, may offer a therapeutic advantage.
In the human atria, the voltage-gated potassium channel Kv1.5 underlies a major repolarizing current, I Kur . The role of I Kur in the control of action potential duration and atrial refractory period highlights its importance in atrial excitability and recognition as a major target for the treatment of AF. [7] [8] [9] [10] Furthermore, loss-of-function mutation in potassium voltagegated channel, shaker-related subfamily, member 5 has been shown to cause AF in humans. 8 Despite the emergence of multiple new anti-arrhythmic drugs that target I Kur , effective cardioversion with clinical efficacy and safety has yet to be achieved. 11 Drug-induced internalization of Kv1.5 in atrial myocytes 12 suggests a novel therapeutic avenue for the acute termination of AF through manipulation of ion channel trafficking, which may avoid the nonselectivity associated with pore-block of potassium channels. One limiting factor shared by these approaches is that during the transition from paroxysmal to permanent AF, there is a marked reduction in I Kur , accompanied by a decrease in Kv1.5 protein expression. 10 The electric remodeling, and decreased Kv1.5 sensitivity to anti-arrhythmic compounds during chronic AF, 13 highlights the need for more understanding of the molecular mechanisms regulating Kv1.5 surface density.
Chronic AF is characterized by both electric and structural remodeling that includes cytoskeletal rearrangement during the progression of this disease. [14] [15] [16] [17] Given that protein trafficking is thought to occur through a cooperation of long-range trafficking, along microtubules, and short-range movement, along actin filaments in the periphery, such a disruption could abrogate significantly cell surface levels and localization of cardiovascular ion channels. [18] [19] [20] [21] [22] There is evidence for a role of the microtubule and actin cytoskeleton in the regulation of Kv1.5 current [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] linking the disruption of the actin cytoskeleton and Kv1.5 trafficking to the onset of AF. 34 Furthermore, this disruption of Kv1.5 trafficking was shown to cause arrhythmias and sudden arrhythmic death in mice.
In general, the molecular machinery identities of the molecular motors and adaptors regulating ion channel trafficking in the cardiovascular system remain unknown. Here we report, for the first time, the role of the unconventional myosin motors, MYO5A and MYO5B in determining the cell surface level of Kv1.5, in cardiomyocytes and show a specific role for MYO5B coupling to Rab11 to control channel recycling.
Methods
See online-only Data Supplement for detailed Methods.
Immunocytochemistry
Immunocytochemistry was performed, and all images were collected, quantified, and analyzed as reported earlier.
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Electrophysiology
Whole-cell voltage clamp experiments were performed on adult rat ventricular myocytes and HL-1 cells expressing Kv1.5-green fluorescent protein (GFP) at room temperature as described previously.
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Ventricular Myocyte Isolation
Adult rat and mouse neonatal ventricular myocytes were isolated using previously established protocols.
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Quantification of Connexin-43 Gap Junction Plaque Density
To quantify connexin-43 (Cx43) expression at cell-cell borders, maximum intensity projections of 10-μm confocal z-stacks were generated for N-cadherin (to identify borders) and Cx43. We then implemented a MATLAB routine, which generates 10-μ fluorescence intensity profiles bisecting traced cell-cell borders. This routine is freely available on request.
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Results
Disruption of MYO5A or MYO5B Inhibits I Kur Current in Adult Rat Myocytes
Kv1.5 trafficking, surface expression, and function depend on interaction with the actin cytoskeleton, 27, 29 as well interactions with PDZ domains of PSD-95, SAP97, and α-actinin-2. [29] [30] [31] [32] 37 Although these data indicate a connection of the actin cytoskeleton with Kv1.5 localization, the direct mechanistic link between actin filaments and trafficking of Kv1.5 to the plasma membrane is unknown. Two candidate unconventional myosin motors, MYO5A and MYO5B, transport cargo along actin 38, 39 ; however, protein presence is unknown. Using specific antibodies, endogenous MYO5A and MYO5B were detected via Western blot in protein lysates from both rat heart and HL-1 atrial myocytes ( Figure 1A) .
To address the importance of MYO5A and MYO5B in determining Kv1.5 current levels in native myocytes, we developed replication-deficient adenoviral vectors coding for only their cargo-binding domains (globular tail domain). These constructs act as dominant negatives (DN) by sequestering cargo in the presence of endogenous motor and discriminate between their functional roles. Although Kv1.5 is atrial specific in humans, in rodents it is expressed in both atria and ventricles. To study channel trafficking in native myocytes, we used acutely dissociated adult rat ventricular myocytes. Ectopic expression was confirmed by visualization of red fluorescent protein fused to both Myo5DN isoforms ( Figure 1B ). Isolation of I Kur from myocytes was achieved by sequential whole-cell voltage clamp traces using a previously described protocol ( Figure 1C ). 28 Briefly, I ss was subtracted from the previous trace (I Kur +I ss ) to measure I Kur . Expression of Myo5aDN or Myo5bDN resulted in a significant decrease in I Kur in acutely dissociated ventricular myocytes 24 hours after transduction (53±8% and 58±6%; n≥7 myocytes; P<0.05 and 0.01, respectively; Figure 1D ).
Using a second selective Kv1.5 inhibitor, diphenyl phosphine oxide-1, we confirmed that MYO5aDN and Myo5bDN significantly reduced Kv1.5 current density ( Figure 1D ). Importantly, Myo5DN transduction did not alter I ss in myocytes, showing specificity of this effect and a lack of generalized toxicity because of adenoviral transduction. Together these data indicate a potential role for MYO5a and MYO5B in regulating Kv1.5-encoded I Kur in cardiomyocytes.
MYO5a and MYO5B Control Steady-State Cell Surface Levels of Kv1.5 and Cx43
The selective decrease in I Kur could result from alterations in channel conductance or in the cell surface density of Kv1.5 channel protein. To investigate the underlying mechanism, we used HL-1-immortalized mouse atrial myocytes expressing an extracellular GFP epitope-tagged Kv1.5 (Kv1.5-GFP) that mimics wild-type channel function. 12, 26 In agreement with our native myocyte data, coexpression with Myo5aDN or Myo5bDN resulted in a significant decrease in Kv1.5 current density (64±29% and 34±28% decrease in current density, respectively; n≥5; P<0.05; Figure 2A ). This decrease in current density was greater in the presence of both myosin-V DN isoforms, resulting in a 92±4% decrease in Kv1.5 current. To determine whether the decrease in current density was the result of a reduction in cell surface trafficking, we measured the effect of coexpression of Myo5aDN or Myo5bDN on steady-state cell surface levels of Kv1.5-GFP. Coexpression of Myo5aDN or Myo5bDN with Kv1.5-GFP resulted in a 47±2% and 32±3% decrease in surface channel, respectively (n≥73; P<0.001; Figure 2B ; Online Figure IA ). Coexpression with both Myo5DN constructs further reduced cell surface Kv1.5-GFP by 63±2%. In contrast, coexpression with either Myo5DN construct did not alter the cell surface levels of extracellular-tagged potassium voltage-gated channel, subfamily H (eag-related), member 2 (hERG)-GFP (n≥27; Figure 2C ; Online Figure IB) . Interestingly, our data revealed no change in I ss current, suggesting that hERG, and other channels that make up the I ss current, is unaffected by the disruption of these myosin motors, further suggesting that myosin-V motors act selectively to traffic Kv channel isoforms.
As an alternative, complimentary approach for testing the role of myosin-V in regulating Kv1.5 surface density, we used gene silencing with short hairpin RNA (shRNA) constructs targeted specifically against endogenous Myo5a and Myo5b. To control for efficiency, the shRNA constructs were expressed using lentiviral infection. These shRNA constructs effectively reduced the expression of recombinant MYO5A and MYO5B in infected HL-1 myocytes (Online Figure IIB and IIC) . No decrease in expression was observed when HL-1 cells were transfected with Myo5a or Myo5b carrying silent mutations (shRNA resistant). With the effectiveness and specificity of the myosin gene silencing established, we measured the effects on Kv1.5-GFP surface density. Infection of cells with Myo5a or Myo5b shRNA, but not with the scrambled control, significantly decreased Kv1.5-GFP surface levels (59±2% and 51±2%, respectively; n≥93; P<0.001; Figure 2D ; Online Figure  IIA ). Together these 2 methods strongly implicate MYO5A-and MYO5B-mediated trafficking in determining the steadystate cell surface levels and current density of Kv1.5.
Importantly, we investigated whether myosin-V control of Kv1.5 surface expression is conserved in native cardiomyocytes by analyzing cell surface localization of ectopically expressed Kv1.5-GFP and Kv1.5-specific current density in isolated rat ventricular myocytes. Consistent with surface expression data using immortalized HL-1 cells, coexpression of Kv1.5-GFP with either Myo5aDN or Myo5bDN resulted in a significant decrease in Kv1.5-GFP cell surface levels compared with mCherry control (n≥28; P<0.001; Figure 3A and 3B). Under whole-cell voltage clamp, coinfection of Kv1.5-GFP with either Myo5aDN or Myo5bDN significantly decreased Kv1.5-specific current density (n≥6; P<0.05; Figure 3D ). Comparison of Kv1.5 channel proteins at the surface of live-cells ( Figure 3A ) and that of permeabilized cells ( Figure 3C ) revealed that the observed decreases in both the cell surface density and the current density of Kv1.5 were because of a population of Kv1.5 channels, which was restricted to the interior of the cell. Although little or no Kv1.5-GFP surface expression was detected in the presence of Myo5aDN and Myo5bDN, the permeabilized cells show an accumulation of channel just under the surface at the cell border, particularly in the presence of Myo5aDN. Although our data indicate that MYO5A and MYO5B show selectivity for Kv channel isoforms, we tested whether they play a role in the regulation of other proteins found at the cell-cell border. Deletion of Cx43 in human atrial tissue has been associated with trafficking defects and the onset of AF, 36, 40 therefore, we investigated the trafficking and surface localization of Cx43 at the gap junctions found at cell-cell borders by monitoring its distance from the cell border of neonatal mouse ventricular myocytes. Myocytes were transduced with adenoviral LacZ, Myo5aDN, or Myo5bDN, in the presence of brefeldin A, to inhibit the anterograde movement of the Cx43 protein to the plasma membrane. After 12 hours of brefeldin A treatment, the majority of Cx43 in the cytoplasm and at cell-cell borders is degraded and new Cx43 is localized in the endoplasmic reticulum, appearing diffuse throughout the cell interior. This technique allows for enrichment of Cx43 early in the vesicular transport pathway and, with washout, to subsequently study anterograde transport in the absence of confounding signal from Cx43 already at the cell surface. Two hours after washout, Cx43 is apparent in perinuclear Golgi apparatus, and at 4 hours, the majority of Cx43 enriched in the endoplasmic reticulum will have had sufficient time to traverse the vesicular transport pathway and have undergone delivery to the cell cortex. 36 Four hours after washout, quantification of Cx43 expression at cell-cell borders ( Figure 4C ) was achieved using a MATLAB routine to generate 10-μm fluorescence intensity profiles perpendicular to and bisecting traced cell-cell borders. 41 The wider intensity profile ( Figure 4C , red) of Cx43 distribution in the presence of the Myo5aDN indicates accumulation of Cx43 in subcortical nonborder regions. These data are consistent with Kv1.5 channel data in the presence of the Myo5aDN and Myo5bDN and suggest that the MYO5A motor is not specific for the regulation of Kv1.5 channel proteins.
MYO5A and MYO5B Regulate the Intracellular Trafficking of Kv1.5 Along Actin Filaments at the Periphery of the Myocyte
To investigate whether the decrease in Kv1.5-GFP surface localization was because of a loss of channel trafficking on actin filaments, we first confirmed a role for the intact actin cytoskeleton in modulating surface density of the channel. Acute treatment with cytochalasin D resulted in a time-dependent decrease in surface Kv1.5 that was significant after 1 hour and culminated in a 56±6% decrease after 6 hours (n≥85; P<0.001; Figure 5A ; Online Figure III) . To demonstrate directly the motility of Kv1.5-GFP vesicles on actin filaments, we performed live-cell, time-lapse imaging, 16 to 20 hours after transfection, followed by retrospective immunofluorescence labeling and static imaging of the actin cytoskeleton ( Figure 5B ). Kv1.5-GFP-labeled vesicles were visualized clearly moving on phalloidin-labeled actin tracts at the periphery. Retrospective labeling of both phalloidin and tubulin showed Kv1.5-GFP vesicles moving in the anterograde direction on microtubules and transitioning to actin filaments at the myocyte edge. To measure the ensemble characteristics of Kv1.5-GFP motility, we used a SD map to sum all motility events of a time series into 1 image. 23 An overlay of the SD map of Kv1.5-GFP with a retrospectively labeled image of the actin cytoskeleton clearly demonstrates movement of Kv1.5-GFP-containing vesicles on linear tracts marked by phalloidin ( Figure 5C ). This processivity of Kv1.5-GFP-containing vesicles on actin is lost in the presence of Myo5aDN or Myo5bDN. Quantification of trafficking events revealed that coexpression with either myosin-V DN construct significantly reduced both the average distance traveled and the average net velocity of Kv1.5-GFP-contatining vesicles along actin filaments ( Figure 5D ). Kv1.5-GFP alone exhibited an average travel distance of 0.8 μm and a velocity of ≈0.4 μm/s (400 nm/s) consistent with previous literature, [42] [43] [44] [45] [46] whereas coexpression with Myo5aDN or Myo5bDN resulted in a 30±1% and 33±2% decrease in distance and velocity, respectively. These combined results demonstrate that MYO5A and MYO5B contribute to the actin-based transport of Kv1.5 vesicles in HL-1 myocytes.
Myosin-V Isoforms Act at Distinct Steps in the Kv1.5-Trafficking Pathway
The additive nature of the MYO5A-and MYO5B-mediated decrease in current density and surface levels suggested that these 2 myosin-V isoforms might function in different steps in the trafficking pathway of Kv1.5 (Figure 2A and 2B) . Therefore, we next tested whether there was a functional distinction between MYO5A and MYO5B in the intracellular trafficking of Kv1.5 in the heart. Previously, we demonstrated acute inhibition of constitutive endocytosis of Kv1.5 with dynasore, a small molecule inhibitor of dynamin (dyn). 12 Disruption of dyn-mediated endocytosis permits investigation of the role of MYO5A and MYO5B in the pre-and postendocytic trafficking of Kv1.5. Introduction of a single point mutation, S61D, in dyn (dynS61D) significantly reduces GTP hydrolysis efficiency, resulting in a DN form for chronic inhibition of constitutive endocytosis. 47 Expression of dynS61D significantly increased steady-state cell surface Kv1.5-GFP, whereas expression of wild-type dyn resulted in decreased surface Kv1.5-GFP (Online Figure IVA and IVB) . More importantly, although coexpression with dyn significantly increased Kv1.5-GFP internalization, internalization decreased in the presence of dynS61D (Online Figure IVC and IVD) .
We then used dynS61D to elucidate whether MYO5A and MYO5B were acting upstream or downstream of channel endocytosis. DynS61D blocked the Myo5bDN-mediated decrease in steady-state cell surface Kv1.5-GFP (n≥59; P<0.001) but did not affect the decrease in surface Kv1.5-GFP mediated by Myo5aDN ( Figure 6A ; Online Figure VA and VB). These data indicate that MYO5A acts in the pre-endocytic and MYO5B in the postendocytic trafficking of Kv1.5. To investigate their role in anterograde delivery of Kv1.5-GFP to the plasma membrane, we measured the effect of the myosin-V DNs at 6 hours of channel expression when the majority of surface Kv1.5-GFP is derived from anterograde delivery of newly synthesized channel. Six hours after transfection, MYO5aDN but not Myo5bDN significantly reduced cell surface levels of Kv1.5-GFP (41±4.7%; n≥25; Figure 6B ; Online Figure  VIA and VIB). These data are consistent with the regulation Kv1.5 and Cx43 by MYO5A motors in native myocyte studies (Figures 3 and 4) .
To investigate the role of MYO5B in the postendocytic recycling of Kv1.5 to the myocyte membrane, we measured constitutive recycling of Kv1.5-GFP in the presence of the Myo5aDN or Myo5bDN, using a live-cell recycling assay (see online-only Data Supplement Methods). Myo5bDN, but not Myo5aDN, significantly reduced constitutive channel recycling (73±2.8%; n≥74; Figure 6C ; Online Figure VIIA) . Furthermore, this loss of channel recycling through MYO5B led to a partial overlap of Kv1.5-GFP in Rab11 positive perinuclear endosomes in the presence of Myo5bDN. (Figure 6D ; Online Figure VIIB) . Rab11 is associated with recycling proteins to the cell surface, 48, 49 and it has been previously demonstrated that steady-state surface levels of Kv1.5 decrease when coexpressed with GDP-locked Rab mutants. 26 These data demonstrate that MYO5A and MYO5B act in 2 distinct steps in the cell surface trafficking of Kv1.5.
MYO5B-Mediated Channel Recycling Is Dependent on Coupling to Rab11
MYO5A has been previously shown to bind Rab11 and to be involved in vesicle trafficking. 50 MYO5B is less well studied; however, it is known to interact with Rab11 and is essential to the recycling of cAMP-activated chloride channels 51 and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor receptors 52 from recycling endosomes. Previously, we demonstrated a role of Rab11, but not Rab8, in the postendocytic recycling of Kv1.5 in atrial myocytes. 26 To test whether Rab11 couples Kv1.5-containing vesicles with MYO5B during channel recycling, we used recently characterized mutations in MYO5B, which disassociate the motor from Rab-GTPases. 53 Coexpression of Kv1.5 with the Rab11-binding-deficient MYO5B Y1684E/Q1718R (Myo5bYE/QR) resulted in a 52±1.5% decrease in channel surface density (n≥74; P<0.001; Figure 7A ; Online Figure VIIIA ). In contrast, coexpression with the Rab8-binding-deficient MYO5B mutant Q1296L/Y1303C (Myo5bQL/YC) did not alter the steady-state cell surface levels of Kv1.5. More importantly Myo5bYE/QR but not Myo5bQL/YC significantly decreased channel recycling (76±2.2%; n≥83; P<0.001; Figure 7B ; Online Figure VIIIB) . Because with Myo5bDN, Kv1.5-GFP accumulated in Rab11 positive perinuclear endosomes in the presence of Myo5bYE/QR ( Figure 7C ; Online Figure VIIIC) . To demonstrate further the necessity of Rab11 coupling for MYO5B-mediated recycling of Kv1.5, we coexpressed Kv1.5-GFP together with both the constitutively active Rab11 construct and Myo5bYE/QR. Rab11-constitutively active resulted in a significant increase in the steady-state cell surface levels of Kv1.5-GFP (29±3.5%; n≥74; P<0.001) that was abrogated by coexpression with Myo5bYE/QR. (Figure 7D ; Online Figure VIIID) . Therefore, Kv1.5 channel recycling via MYO5B occurs through selective Rab11-mediated coupling to Kv1.5-contaning endosomes. These coordinate trafficking events contribute to the steady-state cell surface levels of Kv1.5 channel protein and thereby likely play a role in determining the electric excitability of native cardiac myocytes. 
Discussion
We report a previously unrecognized role for MYO5A and MYO5B in the selective membrane trafficking of Kv1.5 in cardiac myocytes and elucidated the mechanism by which they act in functionally distinct steps in cell surface trafficking of Kv1.5 to determine I Kur current density selectively in cardiac myocytes. The subunit specificity and functional specialization demonstrated in this study denote a potential therapeutic avenue for the modulation of I Kur in the treatment AF.
In considering channel trafficking pathways as therapeutic targets, it is important to consider that cell surface delivery of cardiovascular ion channels may occur through selective-trafficking mechanisms. We show that MYO5A and MYO5B do not play a role in determining cell surface levels of hERG, or I ss current. This is somewhat surprising, given a common mechanism through the dynein motor complex for retrograde microtubule-dependent trafficking of multiple K + channels, including Kv1.5. 25, 26, 54 However, there are distinct differences in the forward-trafficking signals of channel subunits, implying a complex system for differential regulation of endoplasmic reticulum to Golgi trafficking. 55 With regard to localization, different members of the membrane-associated guanylate kinases family have been shown to interact with specific K + channel subunits to direct localization and regulate surface density. In particular, overexpression of SAP97 increases surface levels of Kv1.5 31, 32, 37 and decreases other Kv channels, 56 whereas calcium/calmodulin-dependent serine protein kinase participates in the targeting of Kir2 channels. 57 Kv channel subunits also show a significant degree of specialization in their association with actin-binding proteins, for example, Kv1.5 interacts α-actinin-2, 27,29,33 filamin with Kv4.2, 58 and cortactin with Kv1.2. 59 Therefore, although some mechanisms of trafficking may be conserved, there are specialized steps along the pathway regulated by selective molecular motors, adaptors, and anchoring proteins. Although additional channels need to be investigated to determine the full extent of selectivity of MYO5A and MYO5B for Kv1.5 channel trafficking, the data presented here further emphasize the potential for selectivity in ion channel trafficking pathways.
An intriguing result from our study is that Kv1.5 and Cx43, 2 proteins enriched at their respective intercalated disk regions, 4, 35, 60 are both regulated by MYO5A. Microtubules are involved in delivery of Cx43 to the intercalated disc, 35, 60 with actin rest stops involved in the forward trafficking pathway. 36 Selectivity for Cx43 and Kv1.5 suggests that myosin motors and actin can contribute to specificity of delivery to membrane subdomains, in particular to the intercalated disc. Future studies will help to understand how the actin and microtubule cytoskeleton interact to target channel delivery to specific cardiomyocyte subdomains.
Modulation of trafficking pathways shows promise for acute cardioversion of arrhythmias; however, its role in the treatment of paroxysmal or persistent AF is less clear. AF is progressive disorder marked by electric and structural remodeling that becomes more established with prolonged arrhythmia. Electric remodeling is characterized by significant decreases in atrial effective refractory period because of alterations in ion channel densities in the membrane. 14 In addition, electric remodeling of the atria alters ion channel sensitivities to anti-arrhythmic drug-mediated block. 13 This may be due, in part, to the marked decrease in Kv channel surface density during AF, 10, 14 reducing the functional channel available for pore-block by anti-arrhythmic drugs. The dependence of Kv1.5 trafficking on actin filaments demonstrated here provides insight into the correlation between electric and structural remodeling during AF. These 2 pathophysiologies may be mechanistically linked through the induction of calcium-activated neutral proteases called calpains. [61] [62] [63] Activation of calpains by calcium overload may underlie the significant decrease in actin protein levels 64 and disorganization of the cytoskeletal networks observed in AF. Calpain has also been implicated in the degradation of α-actinin-2 during ischemia reperfusion injury. [65] [66] [67] [68] Both disruption of the actin cytoskeleton with cytochalasin D or antisense oligonucleotide knockdown of α-actinin-2 alters Kv1.5 channel current density. 27, 29, 33 Given the importance of interaction with the cytoskeleton determining the cell surface levels of Kv1.5 in myocytes, calpain activation may be 1 mechanism linking cytoskeletal disruption to decreases in I Kur during AF. In addition, our results predict that deterioration of the actin cytoskeleton would disrupt myosin-mediated delivery of Kv1.5 to the plasma membrane. Therefore, the ≈50% decrease in I Kur and Kv1.5 protein levels in AF may reflect a combination of decreased cell surface trafficking and enhanced endocytosis of Kv1.5 leading to channel degradation. It is unclear whether the reduction of channel levels is a compensatory response to promote survival or a maladaptive response that should be corrected. Regardless, understanding the precise mechanism regulating surface density of ion channels is an important and necessary step in considering therapeutic strategies that increase or decrease ion channels density in the myocyte membrane ( Figure 8) .
In summary, this report reveals the importance of myosin-V motors in regulating the plasma membrane targeting and cell surface density of Kv1.5 in the myocardium. This is the first report to show a role for these proteins in the trafficking and regulation of cardiovascular proteins, with a functional consequence of their disruption. As evidenced by these data, continued elucidation of the molecular machinery involved in cardiovascular protein trafficking may reveal novel therapeutic targets for the regulation and treatment of cardiovascular disease.
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